Gerd-Rüdiger Burmester

Senior Professor

Charité - Universitätsmedizin Berlin

Germany

Research Interests

Explore related searches

Professors in Germany Professors in Immunology Immunology professors in Germany

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gerd-Rüdiger Burmester is a Senior Professor at Charité – Universitätsmedizin Berlin, Germany. His research encompasses diverse areas including the safety and efficacy of novel treatments for rheumatoid arthritis, the integration of AI in medical diagnostics, and innovative imaging methods for rheumatic diseases. He has recently published articles focusing on the benefit-risk analysis of upadacitinib, pharmacokinetics of biosimilars, and the potential for curing rheumatic conditions.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Collaborators (18)

Bruno Stuhlmüller

Laboratory Head

GERMANY

Gerd-Rüdiger Burmester

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Benefit–risk analysis of upadacitinib versus adalimumab in patients with rheumatoid arthritis and higher or lower risk of cardiovascular disease

Usability, efficacy, and safety of candidate tocilizumab biosimilar CT-P47 self-administration via auto-injector and pre-filled syringe in patients with rheumatoid arthritis: a single-arm, open-label, phase 3 study

Safety Profile of Upadacitinib: Descriptive Analysis in Over 27,000 Patient-Years Across Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Atopic Dermatitis, and Inflammatory Bowel Disease

Medical Expert Knowledge Meets AI to Enhance Symptom Checker Performance for Rare Disease Identification in Fabry Disease: Mixed Methods Study

To optimise the diagnostic process of rheumatic diseases affecting the hands using fluorescence optical imaging (FOI)

Cure as a treatment target in rheumatoid arthritis and systemic sclerosis—achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration

Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT‐P47 and Reference Tocilizumab: A Randomized, Double‐Blind, Phase 1 Study

Rheumatoid factors revisited in the age of biologic therapy.

Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years

Upadacitinib in Rheumatoid Arthritis and Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs: Efficacy and Safety Through 5 Years (SELECT-NEXT)

Sustained responses after anti-CD38 treatment with daratumumab in two patients with refractory systemic lupus erythematosus

Patient-level factors predictive of interstitial lung disease in rheumatoid arthritis: a systematic review

Intestinal Microbiota Reduction Followed by Fasting Discloses Microbial Triggering of Inflammation in Rheumatoid Arthritis

Axial psoratic arthritis: are you a lumper or a splitter?

Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis

Safety profile of upadacitinib over 15 000 patient-years across rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis and atopic dermatitis

Celebrating the global impact of rheumatology research: preface to the Viewpoint Article—‘What are the hot topics in Japanese rheumatology?—Go above and beyond’ by Yoshiya Tanaka, Japan

Non-pharmacological interventions to promote work participation in people with rheumatic and musculoskeletal diseases: a systematic review and meta-analysis from the EULAR taskforce on healthy and sustainable work participation

EULAR recommendations for the management and vaccination of people with rheumatic and musculoskeletal diseases in the context of SARS-CoV-2: the November 2021 update

Fluorescence-optical imaging as a promising easy-to-use imaging biomarker to increase early psoriatic arthritis detection in patients with psoriasis: a cross-sectional cohort study with follow-up

Collaborators (18)

Bruno Stuhlmüller

Casper Webers

Peter C. Taylor

Philippe Dieude

Tanja Stamm

Janet Pope

Roy Fleischmann

Féline Kroon

Piotr Klimiuk

Anika Rajput Khokhar

vibeke strand

Berthold Hoppe

Aurélie Najm

Johannes Bijlsma

Maarten Butink

Peter Nash

Robert Biesen

Udo Schneider

Make your next move.